During the past decade, Synexus Clinical Research US, Inc. conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 9 clinical trials were completed, i.e. on average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 9 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Clinical Research US, Inc." #1 sponsor was "Allergan" with 3 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Karuna Therapeutics" with 3 trials sponsored, "ACADIA Pharmaceuticals Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc." #1 collaborator was "Cognitive Research Corporation" with 1 trials as a collaborator and "Neumora Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc." are "Schizophrenia" (10 trials), "Episodic Migraine" (3 trials), "Adjunctive Treatment of Major Depressive Disorder" (2 trials), "Depressive Disorder, Major" (2 trials) and "Lower Respiratory Tract Disease" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc." in a lesser frequency.

Most popular intervention types in "Synexus Clinical Research US, Inc." are "Drug" (18 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Atogepant" (3 trials), "Xanomeline and Trospium Chloride Capsules" (3 trials), "Pimavanserin" (2 trials) and "Seltorexant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Clinical Research US, Inc." are 20 trials for "All" genders.

Currently, there are NaN active trials in "Synexus Clinical Research US, Inc.". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Synexus Clinical Research US, Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Clinical Research US, Inc., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".